225 related articles for article (PubMed ID: 25052307)
21. Systemic lupus erythematous and malignancy risk: a meta-analysis.
Cao L; Tong H; Xu G; Liu P; Meng H; Wang J; Zhao X; Tang Y; Jin J
PLoS One; 2015; 10(4):e0122964. PubMed ID: 25885411
[TBL] [Abstract][Full Text] [Related]
22. Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus.
Mok CC; Ho LY; To CH
Scand J Rheumatol; 2009; 38(5):362-8. PubMed ID: 19296403
[TBL] [Abstract][Full Text] [Related]
23. Cancer risk in systemic lupus: an updated international multi-centre cohort study.
Bernatsky S; Ramsey-Goldman R; Labrecque J; Joseph L; Boivin JF; Petri M; Zoma A; Manzi S; Urowitz MB; Gladman D; Fortin PR; Ginzler E; Yelin E; Bae SC; Wallace DJ; Edworthy S; Jacobsen S; Gordon C; Dooley MA; Peschken CA; Hanly JG; Alarcón GS; Nived O; Ruiz-Irastorza G; Isenberg D; Rahman A; Witte T; Aranow C; Kamen DL; Steinsson K; Askanase A; Barr S; Criswell LA; Sturfelt G; Patel NM; Senécal JL; Zummer M; Pope JE; Ensworth S; El-Gabalawy H; McCarthy T; Dreyer L; Sibley J; St Pierre Y; Clarke AE
J Autoimmun; 2013 May; 42():130-5. PubMed ID: 23410586
[TBL] [Abstract][Full Text] [Related]
24. A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study.
Löfström B; Backlin C; Sundström C; Ekbom A; Lundberg IE
Ann Rheum Dis; 2007 Dec; 66(12):1627-32. PubMed ID: 17517757
[TBL] [Abstract][Full Text] [Related]
25. Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies.
Castillo JJ; Mull N; Reagan JL; Nemr S; Mitri J
Blood; 2012 May; 119(21):4845-50. PubMed ID: 22496152
[TBL] [Abstract][Full Text] [Related]
26. [The occurrence of malignancies in a Hungarian lupus population].
Tarr T; Szekanecz E; Zeher M; Szegedi G; Kiss E
Orv Hetil; 2006 Nov; 147(46):2229-33. PubMed ID: 17396395
[TBL] [Abstract][Full Text] [Related]
27. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
28. Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies.
Onishi A; Sugiyama D; Kumagai S; Morinobu A
Arthritis Rheum; 2013 Jul; 65(7):1913-21. PubMed ID: 23576072
[TBL] [Abstract][Full Text] [Related]
29. Malignancy and systemic lupus erythematosus.
Bernatsky S; Clarke A; Ramsey-Goldman R
Curr Rheumatol Rep; 2002 Aug; 4(4):351-8. PubMed ID: 12126588
[TBL] [Abstract][Full Text] [Related]
30. Hematological malignancies in systemic lupus erythematosus: clinical characteristics, risk factors, and prognosis-a case-control study.
Zhang Y; Li W; Zhang P; Guo J; Sun J; Lu J; Liu S
Arthritis Res Ther; 2022 Jan; 24(1):5. PubMed ID: 34980230
[TBL] [Abstract][Full Text] [Related]
31. Global burden of hematologic malignancies and evolution patterns over the past 30 years.
Zhang N; Wu J; Wang Q; Liang Y; Li X; Chen G; Ma L; Liu X; Zhou F
Blood Cancer J; 2023 May; 13(1):82. PubMed ID: 37193689
[TBL] [Abstract][Full Text] [Related]
32. Decreased live births in women with systemic lupus erythematosus.
Vinet E; Clarke AE; Gordon C; Urowitz MB; Hanly JG; Pineau CA; Isenberg D; Rahman A; Wallace D; Alarcón GS; Bruce I; Petri M; Dooley MA; Kalunian K; Maddison P; Aranow C; van Vollenhoven R; Bernatsky S
Arthritis Care Res (Hoboken); 2011 Jul; 63(7):1068-72. PubMed ID: 21425248
[TBL] [Abstract][Full Text] [Related]
33. Non-Hodgkin's lymphoma and family history of hematologic malignancy.
Mensah FK; Willett EV; Ansell P; Adamson PJ; Roman E
Am J Epidemiol; 2007 Jan; 165(2):126-33. PubMed ID: 17071845
[TBL] [Abstract][Full Text] [Related]
34. Long-term immunosuppression and multiple transplants predispose systemic lupus erythematosus patients with cytopenias to hematologic malignancies.
Lanjewar S; McFarlane IM; Parker KN; Saad H; Haddadin M; Hirsch E; Benyaminov F; Kecelli M; Lazaro D; Bukhari Z; Gupta R; Haseeb MA
Medicine (Baltimore); 2021 May; 100(21):e25985. PubMed ID: 34032713
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.
Grönhagen CM; Fored CM; Granath F; Nyberg F
Br J Dermatol; 2011 Jun; 164(6):1335-41. PubMed ID: 21574972
[TBL] [Abstract][Full Text] [Related]
36. Lymphohaematopoietic malignancies in Scottish military veterans: Retrospective cohort study of 57,000 veterans and 173,000 non-veterans.
Bergman BP; Mackay DF; Pell JP
Cancer Epidemiol; 2017 Apr; 47():100-105. PubMed ID: 28236754
[TBL] [Abstract][Full Text] [Related]
37. [Hematologic complications of disseminated lupus erythematosus].
Clauvel JP; Neumann CL; Seligmann M
Ann Med Interne (Paris); 1977 Jan; 128(1):49-56. PubMed ID: 324327
[No Abstract] [Full Text] [Related]
38. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.
Sultan SM; Ioannou Y; Isenberg DA
Rheumatology (Oxford); 2000 Oct; 39(10):1147-52. PubMed ID: 11035137
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of the incidence and trends of hematologic malignancies between Japan and the United States].
Chihara D; Ito H; Matsuo K
Rinsho Ketsueki; 2015 Apr; 56(4):366-74. PubMed ID: 25971266
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology of hematological malignancies.
Rodriguez-Abreu D; Bordoni A; Zucca E
Ann Oncol; 2007 Jan; 18 Suppl 1():i3-i8. PubMed ID: 17311819
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
